Clinical epidemiological characterization of ovarian cancer at the Hospital Ginecobstétrico “Fe del Valle Ramos”
Keywords:
OVARIAN NEOPLASMS, HISTOLOGICAL TYPE, RISK FACTORS.Abstract
Introduction: ovarian cancer occurs as a result of an accumulation of genetic alterations that cause uncontrolled growth and proliferation of epithelial cells.
Objective: to describe the clinical and epidemiological characteristics of ovarian cancer in patients of the Gynecobstetric Hospital “Fe del Valle Ramos” in the period 2018-2022.
Methods: a prospective descriptive study was conducted to determine the clinical and epidemiological characteristics of ovarian cancer in patients of the Gynecobstetric Hospital “Fe del Valle Ramos” in the period 2018-2022. We worked with 100 % of the universe (60 patients); therefore, sample criteria were not used. The results are presented in tables, using theoretical, empirical and statistical-mathematical methods (percentage calculation).
Results: patients over 45 years of age predominated (73,3 %) and the municipality of Manzanillo (50 %). The main comorbidity was obesity (51,6 %). The most prevalent risk factor was the history of ovarian cancer for 68,3 %. The most prevalent histological type was epithelial cancer. (86,6 %), subtype: serous Most patients were clinical stage III (36,6 %) of ovarian tumour. Surgery was used as the prevailing treatment (86,6 %).
Conclusions: ovarian neoplasia predominates in patients older than 45 years, is associated with comorbidities such as obesity, has a high incidence in patients with a history of ovarian cancer, is predominant the epithelial histological type. It is a cancer that is usually diagnosed in advanced stages (III and IV), which gives it a worse prognosis. Surgery is the fundamental basis of treatment.
Downloads
References
1. Organización Mundial de la Salud. Cáncer [Internet]. OMS; 2018 [citado 16/08/2021]. Disponible en: https://www.who.int/es/news-room/fact-sheets/detail/cancer
2. International Agency for Research on Cancer. GLOBOCAN 2018: Estimated Cancer Incidence, Mortality and Prevalence Worldwide in 2018 [Internet]. Lyon: OMS; 2018 [citado 16/08/2021]. Disponible en: https://gco.iarc.fr/AmericanCancerSociety
3. Instituto Nacional del Cáncer (enero 2018). Tratamiento del cáncer de ovario. [Internet]. 2018 [citado 16/08/2021]. Disponible en: https://www.cancer.gov/espanol/tipos/ovario/paciente/tratamiento-epitelial ovario-pdq
4. Sequeira Robles GC. Epidemiología del cáncer de ovario en pacientes intervenidas por servicios no oncológicos referidas a oncología del Hospital Bertha Calderón Roque en el periodo de enero del 2015 a diciembre del año 2017 [Tesis]. Managua: Universidad Nacional Autónoma de Nicaragua; 2018 [citado 16/08/2021]; Disponible en: https://repositorio.unan.edu.ni/9051/
5. Jean Guerra C, Franco Calderaro DG. Importancia de las características sociodemográficas y epidemiológicas en el manejo de los tumores de ovario. Rev Digit Post [Internet]. 2020 [citado 16/08/2021]; 9(3). Disponible en: https://portal.amelica.org/ameli/jatsRepo/101/1011187012/101118
6. Cortés Morera A, Ibáñez Morera M, Hernández Lara A, García Carranza MA. Cáncer de Ovario: Tamizaje y diagnóstico imagenológico. Medicina. pierna. Costa Rica [Internet]. marzo de 2020 [citado 06/02/2023]; 37(1): 54-61. Disponible en: https://www.scielo.sa.cr/pdf/mlcr/v37n1/2215-5287-mlcr-37-01-54.pdf
7. Menon U, Karpinskyj CH, Gentry MA. Prevención y detección del cáncer ovárico. Obstet Gynecol [revista en Internet]. 2018 [citado 19/05/2022]; 131(2): 909-27. Disponible en: https://journals.lww.com/greenjournal/Documents/May2018_Translation_Menon.pdf
8. González Fernández H, Morales Yera R, Santana Rodríguez S, Reinoso Padrón L, Heredia Martínez B. Caracterización clínico-epidemiológica del cáncer de ovario. Revista Finlay [Internet]. 2021 [citado 06/02/2023]; 11(4): 359-370. Disponible en: http://revfinlay.sld.cu/index.php/finlay/article/view/1071
9. Pérez Cutiño M, Alonso Remedios A, González Ortega E. Expresión del receptor de factor de crecimiento epidérmico en cáncer de ovario. Rev Cubana Obstet Ginecol [Internet]. 2018 Jun [citado 06/02/2023]; 44(2): 1-11. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-600X2018000200018&lng=http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S0138-600X2018000200018&lng=es
10. Sociedad Española de Oncología Médica SEOM. Factores asociados a cáncer de ovario [Internet]. 2020 [citado 24/03/2022]. Disponible en: https://seom.org/info-sobre-el-cancer/ovario?showall=1
11. Sánchez Vega JF, Vintimilla Condoy AS. Marcador CA-125, en tumores epiteliales malignos de ovario y factores asociados, en pacientes del Instituto del Cáncer Solca, Cuenca 1996–2016. [Tesis]. Universidad de Cuenca. Cuenca-Ecuador; 2017. [citado 24/03/2022]. Disponible en: http://dspace.ucuenca.edu.ec/handle/123456789/27268
12. Rocha Monjará B, Zermeño Nava J. Sácido siálico y otros factores asociados en el diagnóstico de cáncer de ovario en pacientes con masas anexiales. [Tesis]. Universidad Autónoma de San Luis Potosí; 2020. Disponible en: https://repositorioinstitucional.uaslp.mx/xmlui/handle/i/5928
13. González Mariño MA. Carcinoma seroso de virio. Serie de 14 casos y revisión bibliográfica. Gineco. Obste. Mex. [Internet]. 2021 [citado 24/03/2022]; 88(7). Disponible en: https://www.scielo.org.mx/scielo.php?pid=S0300-90412020000700004&script=sci_arttext_plus&tlng=es
14. Vásquez Cuela RS, Acosta Evangelista ZL. Factores de riesgo asociados a la prevalencia del cáncer de ovario en el HNDM del 2013 al 2017 [Tesis]. Universidad Nacional Mayor de San Marcos. Lima-Perú; 2019 [citado 24/03/2022]. Disponible en: https://cybertesis.unmsm.edu.pe/bitstream/handle/20.500.12672/10338/Vasquez_cr.pdf?sequence=3&isAllowed=y
15. Zambrano B, Santos M, Díaz L, Omaña D. Experiencia en el tratamiento del cáncer ovárico avanzado. Rev Venez Oncol [Internet]. 2017 [citado 24/03/2022]; 29(4). Disponible en: https://www.redalyc.org/jatsRepo/3756/375652706004/html/index.html
16. García Alonso I, Linchenat Lambert A, Pérez Martínez R, Silveira Pablos M, Esperón Noa R, Aguilar Vela de Oro K. Estudio longitudinal: Cáncer de Ovario en el Instituto Nacional de Oncología y Radiobiología de Cuba (INOR), resultados del tratamiento. Rev. Oncol. Ecu [Internet]. 2018 [citado 24/03/2022]; 28(2): 150-162. Disponible en: https://doi.org/10.33821/106
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms: Authors will retain their copyrights and grant the journal the right of first publication of their work, which will be publication of their work, which will be simultaneously subject to the Creative Commons Attribution License (CC-BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g.: deposit it in an institutional telematic archive or publish it in a volume). Likewise, and according to the recommendations of the Medical Sciences Editorial (ECIMED), authors must declare in each article their contribution according to the CRediT taxonomy (contributor roles). This taxonomy includes 14 roles, which can be used to represent the tasks typically performed by contributors in scientific academic production. It should be consulted in monograph) whenever initial publication in this journal is indicated. Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which may produce interesting exchanges and increase citations of the published work. (See The effect of open access). https://casrai.org/credit/
